Direct detection methods for monitoring of therapeutic staphylococcal bacteriophages in clinical samples
Result description
The most promising alternative for effectively treating infections caused by Staphylococcus aureus is the application of therapeutic bacteriophages of the genus Kayvirus. Although the genomic properties of phages are well-studied, new findings are emerging on the pharmacokinetic profiling of phage drugs. The significant factors relevant to the therapeutic use of phages include i) optimal dosing, ii) duration of exposure to phages, iii) absence of phage genes for toxins and virulence factors, and iv) selection of phages suitable for the infectious agent1. Currently, there is a lack of methods for capturing and monitoring phages in clinical material. Our study aims to develop a technique for a sufficiently sensitive method for the detection and quantification of phage particles in different types of clinical material during phage therapy and clinical trials.
Keywords
Staphylococcus aureusbacteriophagephage antibiotics synergyphage therapy
The result's identifiers
Result code in IS VaVaI
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Direct detection methods for monitoring of therapeutic staphylococcal bacteriophages in clinical samples
Original language description
The most promising alternative for effectively treating infections caused by Staphylococcus aureus is the application of therapeutic bacteriophages of the genus Kayvirus. Although the genomic properties of phages are well-studied, new findings are emerging on the pharmacokinetic profiling of phage drugs. The significant factors relevant to the therapeutic use of phages include i) optimal dosing, ii) duration of exposure to phages, iii) absence of phage genes for toxins and virulence factors, and iv) selection of phages suitable for the infectious agent1. Currently, there is a lack of methods for capturing and monitoring phages in clinical material. Our study aims to develop a technique for a sufficiently sensitive method for the detection and quantification of phage particles in different types of clinical material during phage therapy and clinical trials.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
—
OECD FORD branch
10606 - Microbiology
Result continuities
Project
LX22NPO5103: National Institute of Virology and Bacteriology
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Basic information
Result type
O - Miscellaneous
OECD FORD
Microbiology
Year of implementation
2023